ID   CP4V2_RAT               Reviewed;         525 AA.
AC   A2RRT9;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 1.
DT   24-JUL-2024, entry version 108.
DE   RecName: Full=Cytochrome P450 4V2;
DE   AltName: Full=Docosahexaenoic acid omega-hydroxylase CYP4V2 {ECO:0000250|UniProtKB:Q6ZWL3};
DE            EC=1.14.14.79 {ECO:0000250|UniProtKB:Q6ZWL3};
DE   AltName: Full=Long-chain fatty acid omega-monooxygenase {ECO:0000250|UniProtKB:Q6ZWL3};
DE            EC=1.14.14.80 {ECO:0000250|UniProtKB:Q6ZWL3};
GN   Name=Cyp4v2; Synonyms=Cyp4v3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000312|EMBL:AAI31847.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung {ECO:0000312|EMBL:AAI31847.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: A cytochrome P450 monooxygenase involved in fatty acid
CC       metabolism in the eye. Catalyzes the omega-hydroxylation of
CC       polyunsaturated fatty acids (PUFAs) docosahexaenoate (DHA) and its
CC       precursor eicosapentaenoate (EPA), and may contribute to the
CC       homeostasis of these retinal PUFAs. Omega hydroxylates saturated fatty
CC       acids such as laurate, myristate and palmitate, the catalytic
CC       efficiency decreasing in the following order: myristate > laurate >
CC       palmitate (C14>C12>C16). Mechanistically, uses molecular oxygen
CC       inserting one oxygen atom into a substrate, and reducing the second
CC       into a water molecule, with two electrons provided by NADPH via
CC       cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase).
CC       {ECO:0000250|UniProtKB:Q6ZWL3}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoate + O2 + reduced [NADPH--hemoprotein reductase] =
CC         12-hydroxydodecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:38947, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:18262, ChEBI:CHEBI:36204, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210; Evidence={ECO:0000250|UniProtKB:Q6ZWL3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38948;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWL3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=O2 + reduced [NADPH--hemoprotein reductase] + tetradecanoate =
CC         14-hydroxytetradecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:40203, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:30807, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210,
CC         ChEBI:CHEBI:77033; Evidence={ECO:0000250|UniProtKB:Q6ZWL3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40204;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWL3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoate + O2 + reduced [NADPH--hemoprotein reductase] =
CC         16-hydroxyhexadecanoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:40199, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:15379, ChEBI:CHEBI:55329, ChEBI:CHEBI:57618,
CC         ChEBI:CHEBI:58210; EC=1.14.14.80;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWL3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40200;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWL3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoate + O2 + reduced [NADPH--
CC         hemoprotein reductase] = 20-hydroxy-(5Z,8Z,11Z,14Z,17Z)-
CC         eicosapentaenoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:39791, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:58562,
CC         ChEBI:CHEBI:76639; Evidence={ECO:0000250|UniProtKB:Q6ZWL3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39792;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWL3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + O2 + reduced
CC         [NADPH--hemoprotein reductase] = 22-hydroxy-(4Z,7Z,10Z,13Z,16Z,19Z)-
CC         docosahexaenoate + H(+) + H2O + oxidized [NADPH--hemoprotein
CC         reductase]; Xref=Rhea:RHEA:40155, Rhea:RHEA-COMP:11964, Rhea:RHEA-
CC         COMP:11965, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:77015,
CC         ChEBI:CHEBI:77016; EC=1.14.14.79;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWL3};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40156;
CC         Evidence={ECO:0000250|UniProtKB:Q6ZWL3};
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:P51869};
CC   -!- ACTIVITY REGULATION: Inhibited by N-hydroxy-N'-(4-n-butyl-2-
CC       methylphenyl formamidine)(HET0016) with an IC(50) of 38 nM.
CC       {ECO:0000250|UniProtKB:Q6ZWL3}.
CC   -!- PATHWAY: Lipid metabolism; fatty acid metabolism.
CC       {ECO:0000250|UniProtKB:Q6ZWL3}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q6ZWL3}; Single-pass membrane protein
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC131846; AAI31847.1; -; mRNA.
DR   RefSeq; NP_001129072.1; NM_001135600.1.
DR   AlphaFoldDB; A2RRT9; -.
DR   SMR; A2RRT9; -.
DR   STRING; 10116.ENSRNOP00000019302; -.
DR   PhosphoSitePlus; A2RRT9; -.
DR   PaxDb; 10116-ENSRNOP00000019302; -.
DR   PeptideAtlas; A2RRT9; -.
DR   Ensembl; ENSRNOT00000019302.7; ENSRNOP00000019302.4; ENSRNOG00000042426.3.
DR   Ensembl; ENSRNOT00055020148; ENSRNOP00055016234; ENSRNOG00055011854.
DR   GeneID; 266761; -.
DR   KEGG; rno:266761; -.
DR   AGR; RGD:708530; -.
DR   CTD; 102294; -.
DR   RGD; 708530; Cyp4v3.
DR   eggNOG; KOG0157; Eukaryota.
DR   GeneTree; ENSGT00940000157278; -.
DR   HOGENOM; CLU_001570_5_1_1; -.
DR   InParanoid; A2RRT9; -.
DR   OMA; DIDHMPY; -.
DR   OrthoDB; 1611592at2759; -.
DR   PhylomeDB; A2RRT9; -.
DR   TreeFam; TF105088; -.
DR   Reactome; R-RNO-211976; Endogenous sterols.
DR   Reactome; R-RNO-2453902; The canonical retinoid cycle in rods (twilight vision).
DR   UniPathway; UPA00199; -.
DR   PRO; PR:A2RRT9; -.
DR   Proteomes; UP000002494; Chromosome 16.
DR   Bgee; ENSRNOG00000042426; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0102033; F:long-chain fatty acid omega-hydroxylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0010430; P:fatty acid omega-oxidation; ISS:UniProtKB.
DR   CDD; cd20680; CYP4V; 1.
DR   Gene3D; 1.10.630.10; Cytochrome P450; 1.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   InterPro; IPR036396; Cyt_P450_sf.
DR   InterPro; IPR050196; Cytochrome_P450_Monoox.
DR   PANTHER; PTHR24291:SF189; CYTOCHROME P450 4V2; 1.
DR   PANTHER; PTHR24291; CYTOCHROME P450 FAMILY 4; 1.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; Cytochrome P450; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   2: Evidence at transcript level;
KW   Endoplasmic reticulum; Heme; Iron; Lipid metabolism; Membrane;
KW   Metal-binding; Monooxygenase; NADP; Oxidoreductase; Reference proteome;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..525
FT                   /note="Cytochrome P450 4V2"
FT                   /id="PRO_0000311708"
FT   TRANSMEM        13..33
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   BINDING         329
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /note="covalent"
FT                   /evidence="ECO:0000250|UniProtKB:P51869"
FT   BINDING         467
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250|UniProtKB:P51869"
SQ   SEQUENCE   525 AA;  60580 MW;  D93E3911A6B5D5BD CRC64;
     MLWLWLGLSG QKLLLWGAAS AVSVAGATVL LNILQMLVSY ARKWQQMRPI PSVARAYPLV
     GHALFMKPNN TEFFQQIIQY TEEFRHLPII KLWIGPVPLV ALYKAENVEV ILTSSKQIDK
     SFMYKFLQPW LGLGLLTSTG SKWRARRKML TPSFHFTILE DFLDVMNEQA NILVNKLEKH
     VNQEAFNCFF PITLCALDII CETAMGKNIG AQSNGDSEYV RTVYRMSDMI YRRMKMPWFW
     FDLWYLMFKE GRDHKKGLKS LHTFTNNVIA ERVNARKAEQ DCIGAGRGPL PSKTKRKAFL
     DLLLSVTDEE GNKLSHEDIR EEVDTFMFEG HDTTAAAINW SLYLLGSNPE VQRKVDKELD
     DVFGRSHRPV TLEDLKKLKY LDCVIKETLR VFPSVPLFAR SLSEDCEVAG YKISKGTEAV
     IIPYALHRDP RYFPDPEEFQ PERFFPENSQ GRHPYAYVPF SAGPRNCIGQ KFAVMEEKTI
     LACILREFWI ESNQKREELG LAGDLILRPN NGIWIKLKRR HEDDP
//
